Slide 1: Full Year Results and Business Update Presentation
ASX: ADO FULL YEAR RESULTS AND BUSINESS UPDATE PRESENTATION BRISBANE, AUSTRALIA, 28 AUGUST 2025: AnteoTech Ltd (ASX: ADO) (AnteoTech or the Company) provides the attached Full Year Results and Business Update presentation. The presentation accompanies the live webinar to be hosted by AnteoTech’s CEO
Slide 2: Forward Looking Statements
Forward Looking Statements This Announcement may contain forward-looking statements, including estimates, projections and other forward-looking information (Estimates and Projections). Forward-looking statements can generally be identified by the use of forward- looking words such as “expect”, “anti
Slide 3: Investor Update
Investor Update 28/8/2025 Merrill Gray, MD/CEO 28 August 2025 ©AnteoTech Limited 1
Slide 4: Disclaimer
Disclaimer IMPORTANT INFORMATION The purpose of the presentation is to provide an update of the business of AnteoTech Ltd (ASX:ADO) (AnteoTech). These slides have been prepared as a presentation aid only and the information they contain may require further explanation and/or clarification. According
Slide 5: Agenda
Agenda • Introduction to AnteoTech • Our story • Our patented products and customer offering • Strategy and target markets • Life Sciences including growth pipeline and plans • Advanced Battery Materials including growth pipeline and plans • FY2025 Financial performance • Moving Forward 28 27 August
Slide 6: Introduction to AnteoTech
Introduction to AnteoTech 28 August 2025 ©AnteoTech Limited 4
Slide 7: Who we are
Who we are • AnteoTech Limited is an Australian Stock Exchange listed (ASX:ADO) chemical and materials company, with global sales and an expanding customer base. The Company is at commercialisation and revenue growth stage of development. • AnteoTech’s expertise lies at its core in the application o
Slide 8: Our story
Our story • Our proprietary binding platform technology has applications across multiple industries. • Our current product portfolio comprises of AnteoBind , Anteo X and Ultranode technology. Each • Improves performance and lowers production costs across a range of applications. • The Company’s focu
Slide 9: Our business
Our business Life Sciences • Products, Services - Sales revenue. • Expertise. Patent protected (Family of 8) • Adjacent opportunities. Advanced Battery Technologies . • Products, Technologies, Services – Early revenue. • Expertise. Patent protected (Family of 9) • Adjacent opportunities. Potential o
Slide 10: What our patented products do
What our patented products do Life Sciences Advanced Battery Technologies • Our products strongly link/bind to Binds various molecules together An additive A high silicon and binds molecules to surfaces that anode functional groups of polymers and “cross links” formulation biomolecules, as well as s
Slide 11: What we offer customers
What we offer customers In Life Sciences: AnteoBind and AnteoBind NXT In Advanced Battery Technologies: • Reduce customers costs by: a) Anteo X • Reducing the antibody usage levels in new test • Improves high silicon anode performance and as a result development improves battery performance. • Reduc
Slide 12: Our strategy and target markets
Our strategy and target markets Existing markets where opportunities will continue to be pursued New opportunities to be targeted and pursued Strategy Life Sciences Advanced Battery Technologies India • Targeted, existing network facilitated • Expansion through our SII • E-Mobility, Wearables expans
Slide 13: Life Sciences
Life Sciences Current products Services and know how 28 August 2025 ©AnteoTech Limited 11
Slide 14: Life Sciences and the India market
LIFE SCIENCES Life Sciences and the India market • The global Life Sciences market was valued at ~ US$40 billion in 2024 and projected to grow to around ~US$120 billion (a factor of 3) by 2034, at ~12% CAGR. • India ranks amongst the top global biotech destinations. • The Indian government is heavil
Slide 15: What is it about India?
LIFE SCIENCES What is it about India? Demand at scale 1,450,935,791 people1 Developing nation Two thirds rural population 1 Aging population Median Age 28.8 in 2025 expected to reach 38.3 in 20502 Improved life expectancy Life expectancy of 67 in 2021 expected to reach 84 years in 2045 2 Growing mid
Slide 16: The 'Health for All' Indian Government Initiative
LIFE SCIENCES The ‘Health for All’ Indian Government Initiative 2/3 of India’s Population is Rural 1 Users Pay 2 Means Point of Care/Use Diagnostics are A rapidly growing market based on people’s important to close to 1 billion people. capacity to pay. Source: (1) India Demographics 2024 (Population
Slide 17: Vaccine development & Point of Care lateral flow tests
LIFE SCIENCES Vaccine development & Point of Care lateral flow tests Other opportunities exist to expand product use/applications Pharmaceuticals Biotechnology Immunoassays • Targeted Drug Delivery e.g. in • Biosensor development • Multiplex cancer treatment • Food processing • ELISA • Bioseparation
Slide 18: How AnteoBind works
LIFE SCIENCES How AnteoBind works 28 August 2025 ©AnteoTech Limited 16
Slide 19: Growth Plans
LIFE SCIENCES Growth Plans Continued growth in India. MARKETS Growth in other markets such as South Korea (e.g. KOMA), USA and Japan. Strategic Partnership engagement in Europe with large chemical companies. Potentially entry into China, with the right partner. APPLICATIONS Expansion into new Growth
Slide 20: Opportunity pipeline
LIFE SCIENCES Opportunity pipeline AnteoBind AnteoBind NXT ~ 80/20 split Leads Marketing Sales Contract Contract in Qualified Lead Qualified Lead Negotiation Place 1 2 • Serum Institute India 6 • Contract value: 32 US$1.8 million 32 • Large Corporates: 4 • Contract • Start ups: 6 duration: ’24 to •
Slide 21: Advanced Battery Technologies
Advanced Battery Technologies Current products Services and know how 28 August 2025 ©AnteoTech Limited 19
Slide 22: The Lithium ion Battery (LiB) supply chain is complex
ADVANCED BATTERY TECHNOLOGIES The Lithium ion Battery (LiB) supply chain is complex UPSTREAM MIDSTREAM DOWNSTREAM LiB LiB MINING/CHEMICALS COMPONENT LiB ASSEMBLY END LiB USE MATERIALS PRODUCTION Newly mined raw materials Processing/ Anode LiB manufacture – End Use • Hard rock & Brines:- Li, Graphite
Slide 23: LiB market is growing rapidly
ADVANCED BATTERY TECHNOLOGIES LiB market is growing rapidly The LiB market had an estimated value of ~US$160 … the LiB market is forecast to grow at a compound billion in 2024… annual growth rate (CAGR) of ~20% between out to 2030. Source: Avicenne Energy 2025 Source: Avicenne Energy 2025 AnteoTech’
Slide 24: The future is in Silicon anodes
ADVANCED BATTERY TECHNOLOGIES The future is in Silicon anodes x10 Growth over the next ten years (off the 2024 base) is forecast Silicon anodes prepare for mainstream deployment with production capacity set to triple in 2024 and grow by a factor of ten out to 2035. Benchmark Minerals Communication 1
Slide 25: Why high silicon anodes?
ADVANCED BATTERY TECHNOLOGIES Why high silicon anodes? • Silicon (Si) has the potential to deliver higher energy density and smaller anodes in LiBs than graphite. • Si possesses very high gravimetric capacity (at 4200 mA h/g, lithiated to Li4.4Si,) relative to Graphite (at a 372 mAh/g) - more than 1
Slide 26: Anteo X performance improvements achieved
ADVANCED BATTERY TECHNOLOGIES Anteo X performance improvements achieved Example: a High Silicon anode formulation, at 20% Si/C including Anteo X Using half the amount of CNT a 38% cycle life improvement was achieved With the addition of Anteo X and binder formulation optimisation. Source: AnteoTech’
Slide 27: Anteo X production facility's expansion capacity
ADVANCED BATTERY TECHNOLOGIES Anteo X production facility’s expansion capacity Located at AnteoTech’s 20,000 liters / 80,000 liters / headquarters in Brisbane year year Our processes are ISO 9001 certified. Current production capacity Capacity to expand 28 August 2025 ©AnteoTech Limited 25
Slide 28: Ultranode is highly customisable
ADVANCED BATTERY TECHNOLOGIES Ultranode is highly customisable Ultranode 95 Ultranode 70 Ultranode X Applications • Targets high energy, low • Balances energy density with • 890 cycles @80% capacity has cycle-life applications e.g. attractive cycle-life been achieved for a 70% silicon Unmanned Aeria
Slide 29: Growth Plans
ADVANCED BATTERY TECHNOLOGIES Growth Plans Growth in USA, off the BDS JDA with a focus on Defense and Security. MARKETS Growth in South Korea working with local Distributor. Growth in India working with Austrade and TIQ in terms of pipeline development. Potentially China, with the right partner. APP
Slide 30: Opportunity pipeline
ADVANCED BATTERY TECHNOLOGIES Opportunity pipeline AnteoX Ultranode Both incl Suppliers Strategics Leads Marketing Sales Qualified Contract Contract in Qualified Lead Lead Negotiation Place 115 8 4 54 2 2 9 50 2 0 4 2 Opportunities by geography 50 6 • 29% Europe 21 • 28% USA/Canada 269 • 11% India •
Slide 31: Financial Performance
Financial Performance 28 August 2025 ©AnteoTech Limited 29
Slide 32: Our sales revenue continues to grow
Our sales revenue continues to grow Total sales revenue AUD$ 1,200,000 $969k 1,000,000 800,000 600,000 x2 $460k $366k 400,000 200,000 0 2023 2024 2025 Product Sales Licence Fees and royalities Contract services Source: ADO Annual Reports and Internal data; 250630 Expense Account Mapping_HM.xlsx; htt
Slide 33: Cash management focus
Cash management focus Real cost reduction of ~ 10% on 2024 was achieved. The R&D tax rebate (A$2.6 m) was accelerated. Total cash costs (pre-R&D rebate) 100% Other • Sales and Distribution, Occupancy • Office overheads, ASX, Investor Relations, Sundry Other Admin Costs 80% corporate Consulting • Con
Slide 34: Operational highlights for FY2025
Operational highlights for FY2025 Strategic Entered into a binding Term Sheet for a Joint Development Agreement to produce and Partnership with commercialise an advanced battery product combining Anteo X cross linker with BDS’s Black Diamond proprietary carbon nanotube technology, to deliver step-ch
Slide 35: Latest News
Latest News EXPANSION INTO KEY ASIAN BATTERY MARKET THROUGH APPOINTMENT OF SOUTH KOREAN DISTRIBUTOR 12 August 2025 MOBIUS LAUNCH La Trobe University 15 August 2025 Sources: https://www.arc.gov.au/news -publications/media/arc -corporate-article/advancing -australian-biotechnology-sector and htt ps://
Slide 36: Strategic partnerships discussions
Strategic partnerships discussions 3 3 Chemical and Battery • Discussions are underway with a range of Materials Supply/ Manufacturers businesses globally. Distribution Companies • Target of Q4 FY26 to provide public transparency around commercial 1 2 engagement structure. Diversified Large Big Phar
Slide 37: Moving Forward
Moving Forward • The Company’s focus is on commercialising our products and growing sales revenue. • Over the past few months there have been foundational changes in relation to people, systems and ways of working that will underpin accelerated commercialisation. • A range of opportunities across gl
Slide 38: Questions?
Questions? 28 August 2025 ©AnteoTech Limited 36
Slide 39: Further materials available
Further materials available Immediately available on AnteoTech’s website: • Product brochures – Anteo X , Ultranode , AnteoBind including NXT and Corporate flyer • AnteoBind NXT “White Paper” – 4 page summary (general) and ~20 page technical expert/customer version In progress/available shortly: • A